ID: ALA4783372

Max Phase: Preclinical

Molecular Formula: C15H11N5

Molecular Weight: 261.29

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  c1cnc2c(Nc3ccc4cnccc4c3)n[nH]c2c1

Standard InChI:  InChI=1S/C15H11N5/c1-2-13-14(17-6-1)15(20-19-13)18-12-4-3-11-9-16-7-5-10(11)8-12/h1-9H,(H2,18,19,20)

Standard InChI Key:  OEWKDSKMXGOOPC-UHFFFAOYSA-N

Associated Targets(Human)

Metabotropic glutamate receptor 4 2320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 1A2 26471 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 2C9 32119 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 2D6 33882 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 3A4 53859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 261.29Molecular Weight (Monoisotopic): 261.1014AlogP: 3.25#Rotatable Bonds: 2
Polar Surface Area: 66.49Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.90CX Basic pKa: 6.71CX LogP: 2.27CX LogD: 2.20
Aromatic Rings: 4Heavy Atoms: 20QED Weighted: 0.58Np Likeness Score: -1.32

References

1. Panarese JD,Engers DW,Wu YJ,Guernon JM,Chun A,Gregro AR,Bender AM,Capstick RA,Wieting JM,Bronson JJ,Macor JE,Westphal R,Soars M,Engers JE,Felts AS,Rodriguez AL,Emmitte KA,Jones CK,Blobaum AL,Conn PJ,Niswender CM,Hopkins CR,Lindsley CW.  (2019)  The discovery of VU0652957 (VU2957, Valiglurax): SAR and DMPK challenges en route to an mGlu PAM development candidate.,  29  (2.0): [PMID:30503632] [10.1016/j.bmcl.2018.10.050]

Source